Septerna (NASDAQ: SEPN) revenue
Septerna reported revenue of $46.0m for fiscal 2025, 4,174.5% more than in fiscal 2024 ($1.1m). Since fiscal 2023 its revenue has grown by 30,331.1%, an average growth of 1,644.5% a year.
Septerna has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 3 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $46.0m | +4,174.5% | −$68.3m | −148.6% |
| 2024 | $1.1m | +611.9% | −$80.8m | −7,518.4% |
| 2023 | $0.2m | — | $2.1m | 1,374.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Septerna revenue compared with its sector
By revenue for its latest fiscal year, Septerna ranks 330th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Septerna, 4,174.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 328th | Lexicon Pharmaceuticals | $49.8m | 60.2% |
| 329th | Protagonist Therapeutics | $46.0m | −89.4% |
| 330th | Septerna | $46.0m | 4,174.5% |
| 331st | TriSalus Life Sciences | $45.2m | 53.4% |
| 332nd | Fennec Pharmaceuticals | $44.6m | −6.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Septerna
- How much revenue did Septerna make in fiscal 2025?
- Septerna reported revenue of $46.0m for fiscal 2025, compared with $1.1m in fiscal 2024.
- How much has the revenue of Septerna grown?
- Between fiscal 2023 and fiscal 2025 it went from $0.2m to $46.0m: 30,331.1% more, an average growth of 1,644.5% a year.
- What was the best year for revenue at Septerna?
- Of its last 3 fiscal years, fiscal 2025, with $46.0m.
- Where does Septerna rank in its sector by revenue?
- It ranks 330th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Septerna come from?
- From the annual report (Form 10-K) that Septerna files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Septerna files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Septerna: the Septerna page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.